本页面由Tiger Trade Technology Pte. Ltd.提供服务

燃石医学

16.64
+0.46502.88%
成交量:3.98万
成交额:65.14万
市值:1.79亿
市盈率:-22.67
高:17.94
开:16.94
低:15.50
收:16.17
52周最高:41.72
52周最低:2.18
股本:1,076.66万
流通股本:483.30万
量比:2.81
换手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-0.7337
每股收益(LYR):-0.7337
净资产收益率:-9.92%
总资产收益率:-4.02%
市净率:2.31
市盈率(LYR):-22.67

数据加载中...

2025/04/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/26

SEC问询函

Form CORRESP - Correspondence
2024/11/26

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/04/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/30

SEC问询函

Form CORRESP - Correspondence
2023/08/11

SEC问询函

Form CORRESP - Correspondence
2023/04/20

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/09/28

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/20

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/12

SEC问询函

CORRESP [Cover] - Correspondence